Singapore markets closed

LLY Jul 2024 800.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
55.500.00 (0.00%)
As of 03:59PM EDT. Market open.
Full screen
Previous close55.50
Open85.00
Bid0.00
Ask0.00
Strike800.00
Expiry date2024-07-26
Day's range47.50 - 85.00
Contract rangeN/A
Volume73
Open interest85
  • Yahoo Finance

    Healthcare stocks at an 'inflection point,' analyst says

    Earnings for healthcare companies have declined for six straight quarters. But analysts have a more positive outlook going into second quarter earnings.

  • Yahoo Finance Video

    Jobless claims, healthcare, small caps: Trading Takeaways

    US weekly jobless claims rose more than expected as leadership from the Federal Reserve has expressed confidence in bringing inflation down. The healthcare sector (XLV) slumped today, leading in sector losses and dropping by over 2%. Lastly, the run that small caps (^RUT) has seen in the past few days has begun to stall out, erasing much of the gains from earlier in the week. Yahoo Finance markets reporter Josh Schafer joins Asking For A Trend to break down the latest market trends for July 18. For more expert insight and the latest market action, click here to watch this full episode. This post was written by Nicholas Jacobino

  • Benzinga

    Eli Lilly's Famed Weight Loss Drug Zepbound Scores Chinese Approval

    On Friday, China’s National Medical Products Administration (NMPA) approved Eli Lilly And Co (NYSE:LLY) Tirzepatide for long-term weight management. It is suitable for long-term weight management of adults whose body mass index (BMI) meets the following requirements based on diet control and increased exercise: ≥28 kg/m2 (obese) or ≥24 kg/m2 (overweight) with at least one condition. Tirzepatide is known in the U.S. as Mounjaro for diabetes and Zepbound for weight loss. Related: Chinese Generic O